|Bid||18.74 x 1200|
|Ask||19.33 x 3100|
|Day's Range||18.64 - 20.06|
|52 Week Range||14.20 - 125.66|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 18, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||29.85|
CureVac N.V. ( NASDAQ:CVAC ) shareholders (or potential shareholders) will be happy to see that insider Dietmar Hopp...
Shareholders in CureVac N.V. ( NASDAQ:CVAC ) may be thrilled to learn that the analysts have just delivered a major...
My name is Sarah Fakih, and I'm the vice president of corporate communications and investor relations at CureVac. On the call with me are Franz-Werner Haas, the chief executive officer of CureVac, Klaus Edvardsen, our chief development officer, and Pierre Kemula, chief financial officer of CureVac.